We identified positive correlation between glioma tumour burden and the magnitude of fold change of the CSF3 gene in plasma, suggesting a potential role for this ccfmRNA transcript as a possible biomarker of tumour burden. This evidence concerns the gene CSF3 and central nervous system cancer.